The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: January 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next

Chang, C-Y. et al. Science Advances. 8(46). (2022).
doi: 10.1126/sciadv.abq0615.

Summary of the findings

Environmental airborne nCB particles, found in cigarette smoke and other air pollutants, increase tissue inflammation in the lungs. In addition, nCBs are taken in by the alveolar macrophages, damaging the mitochondria and so favouring glycolysis over oxidative phosphorylation. This leads to increased lactate levels in the microenvironment which impairs the proper functioning of the immune system. This on the background of tissue inflammation favours tumour development.
Smokers are at a higher risk for lung cancer development. However, whether and how ultrafine particles generated by incomplete combustion of organic matter from tobacco, or other sources (e.g., industrial pollution, wildfire, etc.), impact the development and progression of lung cancer remained unclear. In this Science Advances paper, Chang et al. examined the impact of ultrafine nano-sized carbon black (nCB) particles, typically seen in a heavy smoker’s lungs, in two models of lung cancer. They discovered that nCB particles accumulate in alveolar macrophages, altering their cellular metabolism that disables the host’s natural defense against tumors. The biochemical properties of nCB allowed their easy access across macrophage’s cellular lipid bilayer membrane and enter mitochondria. nCB rewired macrophages’ mitochondrial metabolism evidenced by increased glycolysis and higher lactate levels. Increased lactate induced higher PDL-1 expression and immunosuppressive proteins (e.g., Interleukin-10 and arginase) in macrophages that promoted tumor growth and metastasis. Notably, mitochondrial dysfunction and increased glycolytic activity in response to nCB were independent of the tumor, indicating that critical immunosuppressive pathways are driven by macrophages. Adoptive transfer of macrophages carrying nCB fueled lung inflammation and exacerbated lung cancer, supporting how nCB alters the host’s responses allowing cancer cells to evade antitumor immunity.

Future impact

Cigarette smoking remains the number one cause of lung cancer worldwide. However, exposure to industrial and environmental air pollution impacts a broader range of the population at risk. This study shows that small airborne particles, nCB, can promote immunosuppression in the lung, demonstrating the importance of environmental pollutants in cancer development. The newly discovered immunometabolic pathways identified in this study play a key role in lung cancer development and progression. Harnessing the molecular mechanisms critical in changing the immune environment in the lungs could be used to provide new treatment options for preventing and or treating lung cancer.

Read more in Science Advances

 

5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer

  • 1. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
  • 2. A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation
  • 3. Breast tumor microenvironment structures are associated with genomic features and clinical outcome
  • 4. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
  • 6. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
  • 7. Deciphering the immunopeptidome in vivo reveals new tumour antigens
  • 8. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment
  • 9. RASA2 ablation in T cells boosts antigen sensitivity and long-term function
  • 10. Sensitisation of cancer cells to radiotherapy by serine and glycine starvation
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

VIDEO |  How to get through “failure” in a research career

VIDEO | How to get through “failure” in a research career

October 16, 2025

Click above to watch At the Early Career Researchers’ Conference 2025, we enjoyed a brilliant programme of diverse sessions from a range of experts, including Joan...

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

July 16, 2025

Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the highlights from Cancer Researchers to Watch: An early career showcase (Lisbon, 15-16 June 2025). The EACR's...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: July 2025

October 17, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Charles Swanton wins prestigious Mike Price Gold Medal Award 2026
News

Charles Swanton wins prestigious Mike Price Gold Medal Award 2026

November 11, 2025
Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast
Podcast

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast

November 7, 2025
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

Table of Contents

×
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
    • Summary of the findings
    • Future impact
  • 5. Chronic exposure to carbon black ultrafine particles reprograms macrophage metabolism and accelerates lung cancer
→ Table of Contents
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR